SXTC - China SXT Pharmaceuticals Broker Consensus Forecast

Corporate company logo of SXT China (SXTC)

China SXT Pharmaceuticals (SXTC) is a Chinese manufacturer of traditional medicines whose pricing power is constrained by the market of available generics, with the current metric standing at 0.00. This price chart reflects the dynamics of an asset that procures botanical components from third-party suppliers while maintaining control over final processing. The business is currently revising its operating model and restructuring its liabilities due to new product quality requirements.

SXTC - SXT Pharmaceuticals Analyst Consensus Forecast over the range 07/04/2022 - 11/12/2026

Analytical breakdowns for China SXT Pharmaceuticals (SXTC)

- price and consensus price forecast:
General company analysis:SXTC SXT Pharmaceuticals
Flagship merchandise of China SXT Pharmaceuticals, Inc.

This indicator represents the weighted average of target prices from leading investment banks, filtered for market noise to identify the true vector of the asset's valuation revision. By analyzing this consensus target chart, an investor can weigh market expectations against the low margins of China SXT Pharmaceuticals (SXTC) traditional drug supplies to determine a fair entry point given the business's current undervaluation.

Competitors of China SXT Pharmaceuticals

Analyst Median Target haleon.com|Kenvue - Consensus Target|VRNA: Broker Consensus Forecast|MENS: Consensus Target|Ligand Corp - Analyst Forecast Prices|AMRX: Analyst Consensus Forecast|Consensus Target perrigo.com|Price Target Chart Alvotech SA|Liquidia Corp - Forecast Levels Chart|Analyst Consensus Forecast GLPG|ANIP (ANI Pharmaceuticals Corp) - Fair Value Consensus|Analyst Consensus Forecast MNKD (MannKind Corporation)|Analyst Consensus Forecast amphastar.com AMPH|PCRX - Price Target Chart|Fair Value Consensus SPRY (ARS Pharmaceuticals Inc)|Theravance (TBPH) - Price Target Chart|Consensus Target Aquestive Corp|SCPH (scPharmaceuticals, Inc.) - Analyst Consensus Forecast|Analyst Consensus Forecast Tectonic|Consensus Target TNXP (Tonix Pharmaceuticals Holding Corp.)|EPRX (eupraxiapharma.com) - Fair Value Consensus|Price Target Chart BioHarvest BHST|Invizyne (EXOZ) - Average Forecast Price|ORMP: Consensus Target|Entera Bio Ltd. - Analyst Forecast Prices|HYFT: Analyst Consensus Forecast|ABVC BioPharma Inc. - Fair Value Consensus|CPIX (Cumberland Pharma) - Analyst Consensus Forecast|Average Forecast Price Quantum BioPharma Corp QNTM|Price Target Chart FibroGen, Inc. (FGEN)|TELO (telomirpharma.com) - Fair Value Consensus|Analyst Consensus Forecast RANI (Rani Therapeutics Holdings, Inc.)|SNYR - Consensus Target|Rallybio Corp. - Analyst Consensus Forecast|Fair Value Consensus LEXX (Lexaria Bioscience)|PULM: Analyst Consensus Forecast|PTHL - Analyst Median Target|Price Target Chart Aptorum Group Ltd|Broker Consensus Forecast LYRA (Lyra Therapeutics Inc.)|Analyst Consensus Forecast IBO|Analyst Consensus Forecast tnfpharma.com (TNFA)|cbdMD - Consensus Target|Fair Value Consensus PRFX|CYTO - Price Target Chart|Analyst Median Target Lipella Pharmaceuticals Inc LIPO|OPTN (Optinose) - Consensus Target|Broker Consensus Forecast PIRS|Consensus Target PROC|PTPI (petrospharma.com) - Analyst Forecast Prices|Consensus Target QLI (Qilian International Holding)|SLRN (Acelyrin Inc.) - Fair Value Consensus|Price Target Chart TFF Pharma TFFP